These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28633927)

  • 1. Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway.
    Jie L; Pengcheng Q; Qiaoyan H; Linlin B; Meng Z; Fang W; Min J; Li Y; Ya Z; Qian Y; Siwang W
    Eur J Pharmacol; 2017 Oct; 812():196-205. PubMed ID: 28633927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.
    Li J; Qiu P; Wang S; Wu J; He Q; Li K; Xu L
    Biomed Pharmacother; 2019 Jun; 114():108801. PubMed ID: 30928803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
    Hao HH; Shao ZM; Tang DQ; Lu Q; Chen X; Yin XX; Wu J; Chen H
    Life Sci; 2012 Nov; 91(19-20):959-67. PubMed ID: 23000098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
    Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
    Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
    J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
    Chen Y; Chen L; Yang T
    Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.
    Dixon A; Maric C
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1678-90. PubMed ID: 17686959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Tian W; Lei H; Guan R; Xu Y; Li H; Wang L; Yang B; Gao Z; Xin Z
    Drug Des Devel Ther; 2015; 9():5147-57. PubMed ID: 26379427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory effect of compound Coptidis Rhizoma capsule on unbalanced expression of renal tissue TGF-β1/BMP-7 and Smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Chen XQ; Tang LQ; Yu N; Zhang XL; Du HF
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):938-45. PubMed ID: 26087560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxus chinensis ameliorates diabetic nephropathy through down-regulating TGF-β1/Smad pathway.
    Weng HB; Han WK; Xiong YW; Jin ZH; Lan Z; Liu C; Zhang XM; Peng W
    Chin J Nat Med; 2018 Feb; 16(2):90-96. PubMed ID: 29455733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
    Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
    PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.